Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis

Clinical Cancer Research

Volumn 15, Issue 14, 2009, Pages 4680-4685

  Bradbury, Penelope A ^a   Zhai, Rihong ^c   Ma, Clement ^a   Xu, Wei ^a   Hopkins, Jessica ^a,f   Kulke, Matthew J ^d   Asomaning, Kofi ^c   Wang, Zhaoxi ^c   Su, Li ^c   Heist, Rebecca S ^c,e   Lynch, Thomas J ^e   Wain, John C ^e   Christiani, David ^c,e   Liu, Geoffrey ^a,b,c,e  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DNA EXTRACTION; ESOPHAGUS CANCER; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 68049091121     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0192     Document Type: Article

References (28)

1. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549-555 (Pubitemid 32735190)
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Brucher BL, Stein HJ, Zimmermann F, et al. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol 2004;30:963-971 (Pubitemid 39462527)
4. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007;6:273-286
5. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368-4380
6. Balasubramanian SP, Brown NJ, Reed MW. Role of geneticpo lymorphisms in tumour angiogenesis. Br J Cancer 2002;87:1057-1065
7. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-1235
8. Stevens A, Soden J, Brenchley PE, et al. Haplotype analysis of the polymorphich uman vascular endothelial growth factor gene promoter. Cancer Res 2003;63:812-816 (Pubitemid 36231981)
9. Renner W, Kotschan S, Hoffmann C, et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-448 (Pubitemid 32037619)
10. Heist RS, Zhai R, Liu G, et al. VEGF polymorphisms and survival in early-stage non-small cell lung cancer. J Clin Oncol 2008;26:856-862
11. Lu H, Shu XO, Cui Y, et al. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 2005;65:5015-5019 (Pubitemid 40827307)
12. Kim JG, Sohn SK, Chae YS, et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncol 2007;18:1030-1036 (Pubitemid 47050494)
13. Dassoulas K, Gazouli M, Rizos S, et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 2009;48:563-569
14. Schneider BP, Wang M, Radovich M, et al. Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. J Clin Oncol 2008;26:4672-4678
15. Polterauer S, Grimm C, Mustea A, et al. Vascular endothelial growth factor gene polymorphisms in ovarian cancer. Gynecol Oncol 2007;105:385-389 (Pubitemid 46613900)
16. Tzanakis N, Gazouli M, Rallis G, et al. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006;94:624-630 (Pubitemid 44851925)
17. Lurje G, Zhang W, Schultheis AM, et al. Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 2008;19:1734-1741
18. Bradbury PA, Heist RS, Kulke MH, et al. A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Cancer Epidemiol Biomarkers Prev 2008;17:204-211
19. Zhai R, Liu G, Asomaning K, et al. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis 2008;29:2330-2334
20. Zaykin DV, Westfall PH, Young SS, et al. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002;53:79-91.
21. Cordell HJ. Estimation and testing of genotype and haplotype effects in case-control studies: comparison of weighted regression and multiple imputation procedures. Genet Epidemiol 2006;30:259-275
22. Sham PC, Rijsdijk FV, Knight J, et al. Haplotype association analysis of discrete and continuous traits using mixture of regression models. Behav Genet 2004;34:207-214 (Pubitemid 38268936)
23. McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostics tudies (REMARK). J Natl Cancer Inst 2005;97:1180-1184 (Pubitemid 41258223)
24. Inoue K, Ozeki Y, Suganuma T, et al. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997;79:206-213
25. Ogata Y, Fujita H, Yamana H, et al. Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study. World J Surg 2003;27:584-589 (Pubitemid 36961131)
26. Couvelard A, Paraf F, Gratio V, et al. Angiogenesis in the neoplastics equence of Barrett's oesophagus. Correlation with VEGF expression. J Pathol 2000;192:14-18
27. Lord RV, Park JM, Wickramasinghe K, et al. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus. J Thorac Cardiovasc Surg 2003;125:246-253 (Pubitemid 36228302)
28. Vallbohmer D, Peters JH, Kuramochi H, et al. Molecular determinants in targeted therapy for esophageal adenocarcinoma. Arch Surg 2006;141:476-81; discussion 81-82 (Pubitemid 43727572)